Patient-reported Outcomes in the Treatment of Schizophrenia
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listedThis study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.
In CharlestownThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Rio de JaneiroThis summary needs review. Please check the official study record and contact the research team for details.
In OsloThis observational study is following people with Emotional Dysregulation to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
In StrasbourgThis summary needs review. Please check the official study record and contact the research team for details.
In CambridgeThis summary needs review. Please check the official study record and contact the research team for details.
In HolbækThis study is ongoing in the United Kingdom. It focuses on treatment-resistant depression.
In United KingdomThis summary needs review. Please check the official study record and contact the research team for details.
In BeijingThis study is looking at whether active rTMS treatment can help people with Treatment Resistant Depression or depression. Participants take part in active rTMS treatment and complete follow-up assessments.
Multiple locations, including HebeiThis summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Des MoinesThis study exists to learn from real-world information that can show how the medication ALTO-203 fits into care. Researchers are trying to understand whether the medication ALTO-203 can improve attention, thinking, or day-to-day functioning.
Multiple locations, including TucsonHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.